PRIVIA HEALTH GROUP INC
PRVANASDAQ🏆 #1673 by market capEarnings Nov 5 · PreUS Equity
$21.84▲ $0.01 (+0.05%)
Market closed · at closeTrack PRVA
Get earnings, price moves & breaking news on Telegram
24h▲ 0.1%
7d▼ 4.5%
14d▼ 3.4%
30d▲ 11.3%
ytd▼ 8.0%
1y▼ 14.6%
🏦Market Cap
$2.79B
Small Cap
📈Revenue Growth (YoY)
22.3%
Healthy
📊Gross Margin
7.6%
Thin
💵FCF Margin
-2.0%
Thin
⚖️P/S Ratio
1.2x
Cheap
Otter Score
68
Fair
PRIVIA HEALTH GROUP INC
PRVAAnalyst Ratings
Price
$21.84
Total
22
Raised
0
Lowered
1
Avg PT
$28.00
H / L
$32 / $24
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Barclays | Reiterated | Equal Weight | 2026-05-26 | $24.00 | +9.90% |
Canaccord Genuity | Reiterated | Buy | 2026-05-08 | $32.00 | +46.50% |
Evercore ISI Group | Reiterated | Outperform | 2026-04-08 | — | — |
Citigroup | Reiterated | Buy | 2026-03-03 | — | — |
Truist Securities | Reiterated | Buy | 2026-03-02 | — | — |
Stephens & Co. | Reiterated | Overweight | 2025-12-04 | — | — |
JP Morgan | Reiterated | Overweight | 2025-11-13 | — | — |
Citizens | Reiterated | Market Outperform | 2025-11-07 | — | — |
JMP Securities | Reiterated | Market Outperform | 2025-08-29 | $30.00 | +37.40% |
Piper Sandler | Reiterated | Overweight | 2025-08-11 | $36.00 | +64.80% |
Baird | Reiterated | Outperform | 2025-04-15 | — | — |
Needham | Reiterated | Buy | 2025-04-10 | $25.00 | +14.50% |
Citizens Capital Markets | Reiterated | Market Outperform | 2025-02-28 | — | — |
RBC Capital | Reiterated | Outperform | 2024-08-14 | $31.00 | +41.90% |
Stifel | Reiterated | Buy | 2024-05-01 | — | — |
TD Cowen | Reiterated | Outperform | 2024-03-01 | — | — |
UBS | Reiterated | Buy | 2024-03-01 | $30.00 | +37.40% |
B of A Securities | Downgraded | Buy → Neutral | 2024-02-22 | — | — |
Credit Suisse | Reiterated | Outperform | 2023-06-22 | $41.00 | +87.70% |
SVB Leerink | Reiterated | Outperform | 2022-11-11 | — | — |
Cowen & Co. | Reiterated | Outperform | 2022-08-12 | $44.00 | +101.50% |
Guggenheim | Reiterated | Buy | 2022-08-12 | $51.00 | +133.50% |
Institution
Barclays
Reiterated · Equal Weight · 2026-05-26
$24.00
+9.90%
Canaccord Genuity
Reiterated · Buy · 2026-05-08
$32.00
+46.50%
Evercore ISI Group
Reiterated · Outperform · 2026-04-08
—
—
Citigroup
Reiterated · Buy · 2026-03-03
—
—
Truist Securities
Reiterated · Buy · 2026-03-02
—
—
Stephens & Co.
Reiterated · Overweight · 2025-12-04
—
—
JP Morgan
Reiterated · Overweight · 2025-11-13
—
—
Citizens
Reiterated · Market Outperform · 2025-11-07
—
—
JMP Securities
Reiterated · Market Outperform · 2025-08-29
$30.00
+37.40%
Piper Sandler
Reiterated · Overweight · 2025-08-11
$36.00
+64.80%
Baird
Reiterated · Outperform · 2025-04-15
—
—
Needham
Reiterated · Buy · 2025-04-10
$25.00
+14.50%
Citizens Capital Markets
Reiterated · Market Outperform · 2025-02-28
—
—
RBC Capital
Reiterated · Outperform · 2024-08-14
$31.00
+41.90%
Stifel
Reiterated · Buy · 2024-05-01
—
—
TD Cowen
Reiterated · Outperform · 2024-03-01
—
—
UBS
Reiterated · Buy · 2024-03-01
$30.00
+37.40%
B of A Securities
Downgraded · Buy → Neutral · 2024-02-22
—
—
Credit Suisse
Reiterated · Outperform · 2023-06-22
$41.00
+87.70%
SVB Leerink
Reiterated · Outperform · 2022-11-11
—
—
Cowen & Co.
Reiterated · Outperform · 2022-08-12
$44.00
+101.50%
Guggenheim
Reiterated · Buy · 2022-08-12
$51.00
+133.50%
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space